BlackRock Advisors’s BioTelemetry, Inc. BEAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$1.94M Sell
86,582
-310
-0.4% -$6.06K ﹤0.01% 1528
2016
Q3
$1.61M Buy
86,892
+20,097
+30% +$379K ﹤0.01% 1575
2016
Q2
$1.09M Buy
66,795
+2,738
+4% +$40.3K ﹤0.01% 1727
2016
Q1
$748K Buy
64,057
+1,376
+2% +$15.4K ﹤0.01% 1884
2015
Q4
$732K Sell
62,681
-6,191
-9% -$78.3K ﹤0.01% 1890
2015
Q3
$843K Sell
68,872
-589
-0.8% -$7.51K ﹤0.01% 1812
2015
Q2
$655K Buy
69,461
+52,182
+302% +$483K ﹤0.01% 1977
2015
Q1
$153K Buy
17,279
+2,161
+14% +$21.8K ﹤0.01% 2837
2014
Q4
$152K Sell
15,118
-38,258
-72% -$328K ﹤0.01% 2807
2014
Q3
$358K Sell
53,376
-152
-0.3% -$1.07K ﹤0.01% 2224
2014
Q2
$384K Sell
53,528
-42,729
-44% -$340K ﹤0.01% 2206
2014
Q1
$971K Sell
96,257
-11,714
-11% -$108K ﹤0.01% 1557
2013
Q4
$857K Buy
107,971
+103,588
+2,363% +$967K ﹤0.01% 1611
2013
Q3
$43K Hold
4,383
﹤0.01% 3221
2013
Q2
$26K Buy
+4,383
New +$14.7K ﹤0.01% 3248

Other funds holding BEAT

BlackRock Advisors's BEAT Position: Q4 2016 in Review

BlackRock Advisors reduced its BioTelemetry, Inc. (BEAT) stake by 0.36% in Q4 2016, selling an estimated $6.06K and leaving 86,582 shares worth $1.94M. The position accounts for ﹤0.01% of the portfolio, ranked #1528.

BlackRock Advisors first reported a position in BEAT in Q2 2013 and has held it in 15 quarters since. 160 funds tracked by Wall St. Rank hold BEAT as of Q4 2016.

  • BlackRock Advisors held 86,582 shares of BioTelemetry, Inc. worth $1.94M as of Q4 2016.
  • BlackRock Advisors sold 310 BioTelemetry, Inc. shares in Q4 2016, an estimated $6.06K.
  • BioTelemetry, Inc. made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #1528 holding.
  • BlackRock Advisors first reported a position in BioTelemetry, Inc. in Q2 2013 and has held it in 15 quarters since.
  • 160 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.